This is irresponsible of Russia. This is clearly not good to rush ahead without full Phase 3 trial results. Phase 3’s larger sample size allows much better study of safety signals & in wider range of patients. Waiting for P3 will allow greater confidence

This is irresponsible of Russia. This is clearly not good to rush ahead without full Phase 3 trial results. Phase 3’s larger sample size allows much better study of safety signals & in wider range of patients. Waiting for P3 will allow greater confidence 🧵https://t.co/1vQzUA7tvw

— Eric Feigl-Ding (@DrEricDing) August 11, 2020